Latest

Diabetes therapy

Intestinal Fructose Metabolism Triggers Glucagon-Like Peptide-1-β-Cell Axis to Prevent Post-Fructose Hyperglycemia

Researchers from Fujita Health University have made a significant discovery in the field of nutritional and metabolic diseases. According to a news report, the team found that fructose ingestion increases circulating glucagon-like peptide-1 (GLP-1) and insulin, which helps to counteract fructose-induced hyperglycemia. The study, published in The Journal of Physiology,

Medical research

New Insights into Schizophrenia: Recent Research, Emerging Therapies, and Future Directions

Researchers from the Neuropsychiatric Hospital have made significant strides in understanding the complexities of schizophrenia, a psychiatric disorder characterized by disruptions in cognition, perception, and behavior. The study, published in the Journal of Exploration of Neuroscience, highlights the genetic, neurochemical, and neurodevelopmental factors that contribute to the disorder. The researchers

Autism spectrum disorders

New Insights into Autism Spectrum Disorder: A Multidimensional Review

Researchers from Jiangxi, China, have conducted a comprehensive review of the latest findings on autism spectrum disorder (ASD), shedding light on the complex neurocognitive alterations that underlie this condition. The review, published in the journal Frontiers in Psychiatry, integrates insights from structural neuroimaging, functional connectivity, molecular biology, cognitive studies, genetics,

Amino acids

Patent Application for Treating Metabolic Disorders with Antagonistic Binding Proteins for GIPR/GLP-1 Receptor Agonist Fusion Proteins

Researchers have developed a novel approach to treating metabolic disorders by fusing a GLP-1 receptor agonist polypeptide with an antagonist glucose-dependent insulinotropic polypeptide receptor (GIPR) antigen binding protein. This fusion protein has shown promise in reducing body weight, improving insulin sensitivity, and promoting glucose tolerance. According to the patent application,